“Americans consume 80 percent of the world’s opioids, but represent just five percent of the global population,” said Brooks. “Over-prescription of opioids and other controlled substances is a problem. In order to solve it, we need to increase awareness about the problem among prescribers and find creative solutions, like this controlled substances pharmacy, to help prescribers better monitor treatment compliance and prevent drug misuse and diversion. I applaud Cordant Health Solutions for their efforts to combat over-prescription while also ensuring that patients receive the medication they legitimately need.”
“Our pharmacy balances and satisfies the community’s need to reduce mortality from prescription drug misuse while helping to care for those with persistent pain who need to take narcotic analgesics,” said Susan Sommer, president and CEO, Cordant Health Solutions. Rep. Brooks actively supported passage this year of the Comprehensive Addiction and Recovery Act, which authorizes $181 million a year to fight opioid medication misuse. She received the Community Anti-Drug Coalitions of America Congressional Leadership Award for her work to combat heroin and opioid abuse.
The Indianapolis facility is Cordant’s third controlled-substances pharmacy in the United States. About Cordant Based in Denver, Cordant Health Solutions™ is at the forefront of combating today’s opioid epidemic through its network of toxicology laboratories and pharmacies. Cordant is committed to providing solutions for payers, clinicians and agencies involved with addiction, criminal justice and pain management. Cordant is one of the only toxicology laboratories that includes a full-service, high-touch pharmacy that specializes in complex management and dispensing of controlled substances. Cordant provides testing protocols and digital case-management tools to help customers become more efficient and effective in using toxicology test results. ###--
RSS